# A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-comparison-of-lipid-and-glycemic-effects-of-pioglitazone-and-rosiglitazone-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ronald Goldberg,David M. Kendall,Mark A. Deeg,John B. Buse,Anthony J. Zagar,Jane Pinaire,Meng H. Tan,Mehmood Khan,Alfonso T. Perez,Scott J. Jacober,for the GLAI Study Investigators |
| Citations | 795 |
| DOI | 10.2337/diacare.28.7.1547 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://diabetesjournals.org/care/article-pdf/28/7/1547/568216/zdc00705001547.pdf |
| OpenAlex ID | https://openalex.org/W2102675827 |
| PMID | 15983299 |
| Type | article |
| Year | 2005 |

## Paper authors

- [David M. Kendall](https://scholariq.org/researchers/david-m-kendall/)
- [John B. Buse](https://scholariq.org/researchers/john-b-buse/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Paper topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.